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ABSTRACT
DNA translesion synthesis (TLS) is a crucial dam-
age tolerance pathway that oversees the completion
of DNA replication in the presence of DNA damage.
TLS polymerases are capable of bypassing a dis-
torted template but they are generally considered in-
accurate and they need to be tightly regulated. We
have previously shown that pol is phosphorylated
on Serine 601 after DNA damage and we have demon-
strated that this modification is important for effi-
cient damage bypass. Here we report that pol is also
phosphorylated by CDK2, in the absence of damage,
in a cell cycle-dependent manner and we identify ser-
ine 687 as an important residue targeted by the ki-
nase. We discover that phosphorylation on serine
687 regulates the stability of the polymerase during
the cell cycle, allowing it to accumulate in late S and
G2 when productive TLS is critical for cell survival.
Furthermore, we show that alongside the phosphory-
lation of S601, the phosphorylation of S687 and S510,
S512 and/or S514 are important for damage bypass
and cell survival after UV irradiation. Taken together
our results provide new insights into how cells can,
at different times, modulate DNA TLS for improved
cell survival.
INTRODUCTION
DNA replication is crucial for the perpetuation of genetic
information. To ensure its completion, cells possess dam-
age tolerance mechanisms that are capable of replicating a
template even when DNA damage is present. One of such
tolerance systems is DNA translesion synthesis (TLS) and
it takes advantage of specialized DNA polymerases to al-
low the progression of the replication fork in the presence of
a distorted template (1). The majority of TLS polymerases
belong to the Y family and include pol, pol, pol and
Rev1 along with the B-family member pol (1). The Y fam-
ily polymerases can bypass the damage by virtue of a more
open catalytic site that can accommodate DNA lesions,
such as cyclobutane pyrimidine dimers (CPDs), created by
exposure to UV light (2). As a trade-off, this wider catalytic
site is prone to errors during nucleotide incorporation, so
TLS polymerases need to be tightly controlled. This regula-
tion is achieved in multiple ways in different model organ-
isms: while in Saccharomyces cerevisae the concentration of
TLS polymerases seems to be regulated (3), in mammalian
cells TLS polymerases are believed to be regulated mainly
by modulating their localization and recruitment to DNA
(3). Post-translational modifications (PTMs) play a funda-
mental role in such control, and numerous lines of evidence
now support the notion that ubiquitylation, SUMOylation
and phosphorylation are crucial in activating and blocking
TLS in different contexts (4–9). Pol is one of the main TLS
polymerases and is the only one that can bypass CPDs in an
error-free manner. The genetic disease, xeroderma pigmen-
tosum variant, which is caused by inactivating mutations in
thePOLH gene, exemplifies its importance (10). Polcan be
considered the archetypal TLS polymerase on the subject of
PTMs as it has been shown to be ubiquitylated, phosphory-
lated and more recently SUMOylated (4–5,7,9,11–12). Pol
is monoubiquitylated on one of four lysines present on its
PCNA (proliferating cell nuclear antigen) interacting region
(PIR) (4). This modification occurs in the absence of DNA
damage and prevents the interaction of the polymerase with
ubiquitylated targets that is mediated by its UBZ (ubiquitin
binding zinc finger) motif. Once ubiquitylated, pol transi-
tions to an inactive state via an intramolecular conforma-
tional change. This structural change allows the UBZ to
make contact with the ubiquitin attached to the PIR, thus
blocking it from binding to other ubiquitylated proteins.
Monoubiquitylation has been shown to prevent pol from
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interacting with PCNA, the polymerase clamp, which plays
a crucial role in controlling damage tolerance. The E3 lig-
ases PirH2 and Mdm2 have been suggested to be responsi-
ble for this regulatory monoubiquitylation of pol and pre-
viously it has been shown to be linked to the proteasomal
degradation of the polymerase (13–15).
While the ubiquitylation of pol appears to have an in-
hibitory effect on TLS, the phosphorylation of the poly-
merase leads to its full activation. After DNA damage pol
is phosphorylated by the PI3 kinase Ataxia Telangiectasia
and Rad3 related (ATR) on serine 601, and this modifica-
tion is required for efficient damage bypass (5). Phospho-
rylation of S601 occurs only on chromatin and it requires
polUBZ and depends on Rad18 but not on PCNA ubiq-
uitylation. In recent years it has been suggested that other
pol residues might be phosphorylated but direct evidence
of their modification is still missing (12).
Here we report that pol exists in multiple phosphory-
lation states even in the absence of DNA damage and its
phosphorylation changes in a cell cycle-dependent manner.
We identify novel phosphorylated sites and show that one
of them (S687) affects pol protein stability.
MATERIALS AND METHODS
Cell culture and treatments
All the experiments in this study were carried out with
SV40-transformed cells cultured in Dulbecco’s modified
Eagle’s medium containing 10% Fetal Bovine Serum.
XP30RO (XP-V, also designated GM3617) carries a ho-
mozygous deletion in the POLH gene, resulting in a trun-
cated protein of 42 amino acids. The SV40-transformed cell
line was originally established by Cleaver et al. (16). The ab-
sence of the pol protein was routinely monitored by im-
munoblotting and by UV sensitivity assays. MRC5V1 cells
(also called MRC5) are SV40-transformed normal lung fi-
broblasts.
eGFP-tagged mutants of pol (S687A and SSSAAA)
cloned in pEGFP-C3 were created by Quickchange site di-
rected mutagenesis (Stratagene) using the following primers
and verified by sequencing:
S687A: primer forward 5′-GCAAAAGAAATCCCAAG
GCCCCTTTGGCCTGCAC-3′, primer reverse 5′-GTG
CAGGCCAAAGGGGCCTTGGGATTTCTTTTGC-3′.




Once obtained, eGFPpol and its mutants were sub-
cloned in pCDNA3.1(+) (Thermo Scientific) by digestion
with NheI and BamHI to obtain plasmids suitable for
the TNT Quick coupled Transcription/Translation system
(Promega).
XP30RO stably expressing S687A or SSSAAA were cre-
ated using previously described procedures (5,17). Briefly
4 × 105 cells were seeded on a 6 cm dish and transfected
(see below) with the relevant construct. After 24 h, the cells
were diluted in four 10-cm dishes and selected in 1 g/ml
G418. Single colonies were collected after 14 days in culture
with cloning discs (Sigma–Aldrich) and expanded. Finally
the clones were screened for the presence of eGFPpol be-
fore enrichment with a cell sorter.
MG132 (Sigma–Aldrich) was used at 10 M for 1, 3 or 6
h. Roscovitine (Selleckchem) was used at the final concen-
tration of 20 M for 1, 3 or 6 h. Dinaciclib (Selleckchem)
was used at the final concentration of 100 nM for 2 or 8 h.
VE-821 (Sellekchem) was used at 10 M for 1 hour.
Cell synchronization was performedwith a double thymi-
dine (Sigma–Aldrich) block and a release in nocodazole
(Sigma–Aldrich) if not otherwise stated. Cells were treated
for 16 h with 2.5-mM thymidine, released in medium with-
out thymidine and then incubated again for 16 h in thymi-
dine. Finally, the cells were released into 50 ng/ml noco-
dazole for up to 16 h and were harvested at different time
points. Transfection was carried out with Viafect (Promega)
orGenejuice (Novagen) according to themanufacturers’ in-
structions.
2D gel electrophoresis
All reagents and solutions for 2D-PAGE (polyacrylamide
gel electrophoresis) were obtained from Bio-Rad except as
noted. Cell pellets were resuspended in 100 l of rehydra-
tion buffer with protease and phosphatase inhibitors and
sonicated for 3 cycles/30 s with a Diagenode Bioruptor.
Benzonase (50U) (Merk Millipore) was added and the ex-
tracts were incubated end over end for 30 min at 4◦C. Sam-
ples were then centrifuged at 13 000 rpm for 30 min at 4◦C
and quantified by Bradford assay. A total of 120 g pro-
tein extract were diluted with rehydration buffer to a final
volume of 200 l.
A total of 200 l of each sample were loaded on a 7 cm
IPG strip (pH3–10) by passive rehydration for 30 min fol-
lowed by an active rehydration in a Bio-Rad Protean i12
IEF cell (14 h 50V 20◦C).
The first dimension was performed at 50 mA on a volt-
age gradient. Following focusing, each strip was incubated
for 20 min twice in equilibration buffer with 20 mg/ml
dithiothreitol (DTT) or 25 mg/ml iodoacetamide (Sigma–
Aldrich) respectively. Strips, embedded in agarose, were
then loaded on 10% polyacrylamide gels.
Electrophoresis was performed at 100 mA for 10 min and
then at a constant current of 200 mA for 60 min.
SDS-PAGE and western blotting
Proteins separated by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) were
transferred onto nitrocellulose membranes. After blocking
in 5% skim milk powder in Tris-buffered saline, pH 7.5,
0.1% Tween-20 for 1 h at room temperature, the membranes
were incubated with primary antibodies overnight at 4◦C.
The membranes were then incubated with secondary
antibody and visualized using an enhanced chemilumines-
cence detection kit (Millipore) on a LAS500 system (GE
Healthcare). Western blots were analyzed with Imagequant
(GE Healthcare).
Antibodies
Antibodies used in this study included: anti-mouse-BrdU
(Becton Dickinson, 1:200); Vimentin (Sigma–Aldrich,
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1:1000); Vinculin (Abcam, 1:1000); Phospho-CDK Sub-
strate Motif [(K/H)pSP] (Cell Signaling 1:1000); Pol (Ab-
cam, 1:1000, used only for detection of eGFPpol); Pol
(custom made 1:500, detects endogenous pol); PolP-687
(custom made, 1:200); PCNA (Santa Cruz, 1:1000).
RNA extraction, RT-PCR and real-time PCR
Total RNA was extracted using a Qiagen RNAKit accord-
ing to the manufacturer’s instructions. One microgram of
total RNA was used for cDNA synthesis with a M-MulV
Reverse Transcriptase Kit (Roche). Amplification condi-
tions were as follows: 60 min at 37◦C followed by 10 min
at 70◦C. Real-time polymerase chain reaction (PCR) was
performed using iTaq™Universal SYBR®Green Supermix
(Bio-Rad) in a LightCycler 480 (Roche). Reactions were run
in triplicate in three independent experiments. The house-
keeping gene used was GAPDH.
The primers used are:
GAPDH: primer forward 5′-ACCACAGTCCATGCCAT
CAC-3′ primer reverse 5′-TCCACCACCCTGTTGCTGT
A-3′.
Pol: primer forward 5′-AGTTCGTGAGTCCCGTGGG
-3′ primer reverse 5′-GCTTGGCAACAAGTCTGCC-3′.
Clonogenic assay
Cell lines expressing different eGFP constructs were seeded
and UV irradiated the following day at the indicated doses.
After 13 days, the number of colonies was assessed af-
ter 70% EtOH fixation and methylene blue staining (0.1%
Page-Blue; 50% MetOH; 7.5% Acid Acetic).
Post-replication repair (PRR) assay
Cells were washed in phosphate-buffered saline (PBS) and
irradiated with 8 Jm−2 as previously described (4). Briefly,
cells were incubated in 2 ml of medium containing 0.3
mg/ml caffeine for 30 min before the addition of 1.85 MBq
of 3H-thymidine. Cells were then released in fresh caffeine-
containing medium (0.3 mg/ml) supplemented with 10 M
thymidine and 10 M deoxycytidine for 150 min. At the
end of the chase period, cells were collected in PBS contain-
ing ethylenediaminetetraacetic acid (EDTA) (0.2 g/l). Cells
were then lysed in 0.2 ml buffer (1% SDS, 0.75M NaOH,
0.75MNaCl, 20 mM EDTA) layered on top of 5 ml of a 5–
20% sucrose gradient (in 0.1 M NaOH, 0.1 M NaCl). After
exposure to visible light for 1 h, the gradients were spun at
38 500 rpm for 70 min in a Sw55 rotor. At the end of the
run, 25 fractions were spotted on Whatman grade 17 pa-
per, precipitated by trichloracetic acid and washed twice in
ethanol before being counted on a Perkin Elmer scintilla-
tion counter. The weight-average molecular weights of the
distributions were calculated as (18), omitting the top and
bottom three fractions.
Flow Cytometry analysis
Cells were harvested after incubation with 30 M bromod-
eoxyuridine (BrdU; Sigma–Aldrich) for 30 min, fixed in 1
ml of cold 70% ethanol and stored at 4◦C. DNA was de-
natured with 2N HCl and 0.5% Triton X-100, then neu-
tralized with 1 ml of 0.1M sodium borate pH8.5. The cell
pellet was resuspended in PBS, 0.5% Tween 20, 1% bovine
serum albumin (BSA) with a mouse anti-BrdU antibody
(Becton Dickinson, Franklin Lakes, NJ, USA) and incu-
bated at room temperature for 1 h, followed by 1-h room
temperature incubation with anti-mouse-488 (Alexa anti-
mouse 488,Molecular Probes/Invitrogen). Samples were fi-
nally incubated with 10 g/ml Propidium Iodide and ana-
lyzed on a S3 flow cytometer (Biorad). Data were analyzed
using the program ProSort (Biorad) or FCS Express (DeN-
ovo).When Propidium Iodide only staining was performed,
cells were fixed in 1 ml of cold ethanol and resuspended in
PBS, 0.1% Tween 20, 50 g/ml Propidium Iodide, 5 g/ml
RNase A. After incubation at 37◦C for 15 min, cells were
analyzed by flow cytometry.
In vitro CDK assay
Assays for pol phosphorylation were performed with
CDK1 and CDK2. The reactions were performed with the
same units of enzymes (10U) or with the same quantity of
enzymes (40 ng). Purified pol was incubated either with
CDK1/cyclin B (Millipore) or CDK2/cyclin A (Millipore)
in reaction buffer (8 mM MOPS/NaOH pH7.0, 2.5 mM
MgAc, 0.05 mMATP, 0.02 mMEDTA) for 10 min at 30◦C.
The reactions were stopped by addition of Laemmli buffer
and boiled at 95◦C for 5 min. Activity of the CDKs was
checked by incubating the kinases withHistoneH1 (Sigma–
Aldrich).
Immunoprecipitation
Harvested cells were lysed with a lysis buffer (0.5% NP40,
40 mM NaCl, 50 mM Tris–HCl pH 7.5, 2 mM MgCl2, 1
mM N-Ethylmaleimide (NEM), protease inhibitors cock-
tail (Roche), phosphatase inhibitors (Roche) and 1 l/ml
Benzonase (Novagen)) and incubated on a rotary wheel
at 4◦C for 30 min. After incubation the mixture was cen-
trifuged at 13 000 rpm for 15 min at 4◦C and the super-
natants were collected and quantified by Bradford assay.
Samples were diluted in four volumes of immunoprecipi-
tation (IP) buffer (125 mMNaCl, 50 mMTris–HCl pH 7.5,
protease inhibitors cocktail (Roche)). Protein extracts were
pre-cleared with Protein A/G magnetic beads (100 l/20
mg of protein, Thermo Scientific), previously equilibrated
with three volumes of IP buffer, before IP with anti-GFP
antibody (Thermo Scientific) bound to protein A/G mag-
netic beads.
Protein purification and MS analysis
Pol−6His, was purified from Escherichia coli as previ-
ously described (19). GST-PCNAwas bought fromThermo
Fisher Scientific. Flag-HA Polwas purified and analyzed
by liquid chromatography-tandemmass spectrometry (MS)
as described in (20).
Phosphatase treatment
A total of 120 g protein extracts were incubated in phos-
phatase buffer (New England Biolabs) with or without
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1600U of  phosphatase (New England Biolabs) for 30 min
at 30◦C. After incubation the reaction was diluted with re-
hydration buffer up to a volume of 200 l and processed as
previously described for 2D-PAGE. Alternatively, immuno-
precipitated proteins were incubated with 800U of  phos-
phatase for 1 h in phosphatase buffer at 30◦C before resus-
pension in Laemmli buffer.
Primer extension assay
Plasmids encoding eGFPpol (WT, S687A and SSSAAA)
or pol-6His (WT and S687A) were used for in vitro
coupled transcription and translation reactions in rabbit
reticulocyte lysate according to manufacturer’s instructions
(Promega). Polymerases were quantified by western blot
analysis and equimolar amounts of proteins were used
for the primer extension assays. A 5′ FAM-labeled 13mer
(5′ GGGTGGAGGTGAC 3′) was annealed with a tem-
plate 33mer primer (5′ TCACACTCTATCACACTC[cis-
syn-TT]GTCACCTCCACCC 3′) containing a thymidine
dimer (TT) at position +14 (TriLink Biotechnologies).
Primer extension assays were performed in 10 l of repli-
cation buffer (40 mM Tris–Cl pH 8, 5 mM MgCl2, 10 mM
DTT, 0.25 mg/ml acetylated BSA, 60 mM KCl, 2.5% glyc-
erol). Reactions were incubated at 37◦C for 15 min and
stopped with 10 l of 2× loading buffer, (98% deionized
formamide, 10 mMEDTA pH 8, 0.025% xylene cyanol and
0.025% bromophenol blue). Samples were boiled at 95◦C
for 5 min and rapidly chilled on ice. Reaction products were
resolved on a 15% acrylamide-7M urea gel and then imaged
on a Typhoon imager (GE HealthCare).
RESULTS
Pol presents multiple phosphorylation states
Wepreviously identified and characterized S601 of poland
discovered how its phosphorylation was crucial for efficient
damage bypass (5). The visualization of the phosphory-
lated state of the polymerase was extremely challenging and
we had to develop a phospho-specific antibody in order to
characterize the function of serine 601. In order to be able to
assess the general phosphorylation state of the polymerase
we adapted a new approach based on 2D SDS-PAGE. This
technique relies on a first dimension that separates the pro-
teins according to their isoelectric point followed by second
dimension under denaturing conditions. This technique al-
lowed us to amplify the small mobility shift caused by
the polymerase phosphorylation as observed by canonical
SDS-PAGE. We were surprised to note that pol separated
in a number of different isoforms (Figure 1A) indicating
that the polymerase could be modified by multiple phos-
phorylation events. To confirm that the different isoforms
we were visualizing were indeed due to phosphorylation,
we treated the cell extracts with −phosphatase. In such
conditions all the negatively charged forms of pol disap-
peared indicating that our experimental approach had re-
vealed multiple phosphorylated forms of the polymerase
(Figure 1A). This finding was unexpected, as polwas pre-
viously shown to be phosphorylated only after DNA dam-
age in order to trigger damage bypass (5). The damage-
dependent phosphorylation of polwas carried out by the
ATR kinase. By exploiting our experimental set-up we con-
firmed that while pol is significantly phosphorylated in the
absence of DNAdamage, after UV exposure its phosphory-
lation profile changes toward a more acidic state (Figure 1B
and C) and we confirmed that this hyper-phosphorylation
was dependent on ATR as it could be abrogated by the
ATR-specific inhibitor VE821 (Figure 1B and C).
Pol is phosphorylated during an unperturbed cell cycle
We wondered if the presence of multiple phosphorylation
states in the absence of DNA damage could have functional
significance in the regulation of the activity of the poly-
merase. In order to assess if the phosphorylation changed
during the cell cycle, we synchronized the cells in early S
phase via a double thymidine block and then released the
cells. This allowed us to sample the global phosphorylation
status of the polymerase at different stages of the cell cycle,
notably during S phase, during anaphase transition and fi-
nally in the G1 of the next cell cycle phase. As can be seen
in Figure 2A and B the phosphorylation of pol increases
toward the end of the S phase before reaching a maximum
when the cells are arrested at the -metaphase-anaphase tran-
sition because of the treatment with nocodazole. Once the
cells reach theG1 phase of the following cell cycle, the phos-
phorylation profile reverts to a more basic state, indicating
that the phosphorylation of pol is cell cycle regulated and
is low in G1 before increasing in late S-G2. A BrdU in-
corporation assay confirmed that the cells progressed syn-
chronously (Figure 2C). The cell cycle-dependent phospho-
rylation of poloccurred alsowhen the cells were released in
the absence of nocodazole, indicating that the progression
through the cell cycle was responsible for the modification
and not the treatment with the drug (Supplementary Figure
S1A).
CDKs are responsible for the cell cycle phosphorylation of
pol
Given the peculiar distribution of pol phosphorylation
through the cell cycle, we investigated if the polymerase
could be the target of CDKs. To address this hypothe-
sis we synchronized the cells in mitosis with nocodazole.
In this condition, the phosphorylation of pol is maxi-
mal, with an evident shift toward an acidic isoelectric point
(compare Figure 3A/B first and second blot). After treat-
ment with nocodazole, the cells were further treated with
two CDK inhibitors, specifically roscovitine and Dinaci-
clib. Both are known to be capable of repressing the activ-
ity of various CDKs (21,22). In both cases we detected a
shift in the mobility of pol, consistent with a reduction in
phosphorylated forms (compare third and fourth blot with
the second in Figure 3A/B). Overall polwas unphospho-
rylated in roscovitine and Dinaciclib-treated cells, indicat-
ing that CDKs played a major role in regulating the cell
cycle-dependent phosphorylation of the polymerase. The
change in pol phosphorylation after CDK inhibition was
also detectable in cycling cells without nocodazole arrest
(Supplementary Figure S1B), indicating that the observed
phenomenon was not due to the synchronization protocol.
Although the phosphorylation was significantly reduced by
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Figure 1. DNA polymerase  is phosphorylated even in the absence of DNA damage. (A) 2D-PAGE analysis of XP30RO cells expressing eGFPpol shows
the protein separating at different isoelectric points. Top blot, cell extract processed before incubation with phosphatase buffer. Middle blot, cell extract
after incubation in phosphatase buffer at 30◦C for 30 min. Bottom blot, cell extract after incubation with -phosphatase in phosphatase buffer at 30◦C for
30 min. The different isoforms disappear after treatment with -phosphatase indicating that they represent phosphorylated forms of the polymerase. The
2D PAGE were aligned by using Vimentin and PCNA as triangulation markers (see Figure 2). The red dotted line is used as reference of the alignment. (B)
DNA polymerase  becomes hyper-phosphorylated after damage in an ATR-dependent manner. (C) Densitometric analysis of the blots presented in B.
the treatments, some modified form of pol persisted, in-
dicating that either redundant CDKs are involved or other
kinases could phosphorylate pol.
At this point, we could only conclude that CDKs were
important in regulating the phosphorylation of pol, but
we did not know if they directly phosphorylated pol or if
the phosphorylation was mediated by one of the plethora
of CDK substrates. To address this point we purified hu-
man pol and performed an in vitro kinase assay. CDK2
and CDK1 are the two major kinases involved in S phase
and G2/M phase progression. For this reason we chose
to test their kinase activity using pol as substrate. Equal
units of CDK1/2 or equal amounts (ng) of active ki-
nases (Supplementary Figure S2A) were incubated with
pol before electrophoresis. In order to monitor the phos-
phorylation activity, we used an antibody able to recog-
nize phosphorylated CDK targets at their consensus mo-
tif ((K/R)(S*)PX(K/R)). As can be seen in Figure 3C,
pol was efficiently phosphorylated by CDK2 but hardly
by CDK1. We therefore concluded that polwas phospho-
rylated directly by CDK2 in a cell cycle-dependent manner.
Identification of new pol phosphorylation sites
To try to identify the specific residues that were phosphory-
lated, Flag-HA-tagged pol (e-Pol) was stably expressed
in HeLa cells. e-Pol was purified, excised from an SDS-
PAGE gel (Figure 4A) and analyzed byMS/MS, leading to
the identification of new putative phosphopeptides. TheMS
analysis confidently assigned a phosphorylation on S687
(Figure 4B, top panel), and another single phosphate on
a peptide containing S510, S512, S514 (Figure 4B, bottom
panel). In this case, it was not possible to pinpoint exactly
which of the three closely clustered serines wasmodified. As
can be seen in Figure 4C, the new phosphorylation sites lie
toward the C-terminus of the polymerase with S510, S512,
S514 located right after the catalytic domain while S687 re-
sides in the Nuclear Localization Signal (NLS).
To verify that the phosphorylated peptides identified in
the MS analysis were indeed phosphorylated, we estab-
lished a series of XP30RO cell lines stably expressing al-
leles of the polymerases that were mutated at S687 and
S510, S512, S514 (SSSAAA). All the alleles were tagged
with eGFP, aswe have previously shown that this tag did not
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Figure 2. DNA polymerase phosphorylation changes during an unperturbed cell cycle. XP30RO cells expressing eGFPpolwere synchronized by double
thymidine block (0) before being released into S phase in the presence of nocodazole. After 16 h, the cells arrested in anaphase and they were subsequently
released into the G1 phase of the next cell cycle (16 + 3). 2D-PAGE shows increasing amounts of phosphorylated pol during the transition from S to
G2/M before a reduction in G1. The dotted line is used as reference of the alignment. (B) Densitometric analysis of the blots presented in A, the asterisk
marks the reference peak as in A. (C) BrdU analysis of the experiment shown in panel A shows a synchronized progression through the cell cycle.
interfere with the protein catalytic activity (Supplementary
Figure S3A), localization or function (4,17,23). We then
performed a 2D-PAGE analysis to assess the phosphory-
lation pattern of the mutants. As can be seen in Figure 4D,
both S687A and SSSAAA showed a marked reduction in
the number of phosphorylated species, going from seven in
the WT to four in each mutant.
Mutations in either of these residues did not completely
abolish the phosphorylation of pol, indicating that S687
and S510, S512, S514 are phosphorylated independently
and other phosphorylated forms of the polymerase are
still present. Furthermore, the isoelectric point of the poly-
merase changed, with a new more basic spot appearing in
the mutants. This could indicate that in the WT all of the
polymerase is phosphorylated and the unphosphorylated
form becomes evident only when some of the phospho-sites
are mutated or the CDKs are inhibited (See Dinaciclib blot
in Figure 3A and B).
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Figure 3. DNA polymerase phosphorylation is dependent on CDKs. XP30RO cells expressing eGFPpolwere synchronized in anaphase by nocodazole
before treatment with CDK inhibitors. (A) 2D-PAGE analysis of pol shows a reduction of phosphorylated forms after treatment with two pan CDK
inhibitors (Dinaciclib and roscovitine). Gels were aligned by using Vimentin (shown) and PCNA (not shown) as first dimension migration markers. (B)
Densitometric analysis of the blots presented in A, the asterisk marks the peak used as reference. (C) In vitro kinase assay with purified pol and purified
CDK1 or CDK2.
Up to this point, we could successfullymonitor the global
phosphorylation status of pol, without being able to dis-
cern specifically the behavior of a specific residue. To over-
come this limitation, we developed a phospho-specific anti-
body raised against P-S687. Unfortunately, we could not es-
tablish an antibody against the other residues due to the dif-
ficulty in pinpointing which serine was modified. The new
antibody was able to detect phosphorylated pol specifi-
cally on S687 as can be seen in Figure 4E. We also verified
that the signal was due to a phosphorylation modification
as a signal was absent when pol was immunoprecipitated
and treated with -phosphatase (Supplementary Figure S2,
compare lanes 3 and 4 with 9 and 10). The development of
this antibody gave us the opportunity to specifically study
this modification in vivo.
S687 is a CDK target and is regulated during the cell cycle
As shown before, the phosphorylation of polwas affected
by CDK inhibitors in vivo and was a direct target of CDK2
in vitro. The identification of new putative phosphorylated
residues prompted us to examine if S687 and S510, S512,
S514 were CDK targets in vivo. After IP, we were not able
to detect a signal from the CDK phospho-specific antibod-
ies when S687A was expressed, while it was unchanged in
the SSSAAA mutant (Figure 5). This suggested that only
S687 was a target of CDKs in vivo. It should also be noted
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Figure 4. Identification of new phosphorylated residues in Pol. (A) e-Polwas purified and extracted from the gel forMS/MSanalysis. (B)MS/MS spectra
of the new phosphorylation sites of pol. B ions are marked in blue and Y ions are marked in red, both in the spectra and the peptide sequences. The top
spectrum represents the peptide containing P-S687 (*site confidently assigned) while the bottom spectrum represents a peptide (aa 495–533) containing a
single phosphate that could not be confidently assigned. Based on the fragmentation pattern the possible location of the phosphate was narrowed down to
S510, S512 or S514. (C) Schematic representation of poldomains and alignment of newly identified phospho-residues. (D) 2D-PAGE analysis of XP30RO
cells expressing eGFPpol carrying S687A or S510A, S512A, S514A allele with respective densitometric analysis. The two mutant alleles show a reduced
phosphorylation pattern. (E) Characterization of a new antibody against P-S687. Cells were transfected with Flag-pol either WT or S687A and probed
with this antibody. Signal is present only in the case of the WT allele.
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Figure 5. Serine 687 is phosphorylated by CDK and changes during the cell cycle and after UV irradiation. (A) eGFPpol either WT, S687A or SSSAAA
was immunoprecipitated from XP30RO derived cell lines and its phosphorylation status was analyzed with antibodies to P-(S)CDK and pS687. (B)
XP30RO cells expressing eGFPpol were synchronized by double thymidine block and released into the cell cycle in the presence of nocodazole, before
IP of eGFPpol. Pol and P-S687A increase in S phase and G2/M. (C) MRC5 cells were transfected with eGFPpol and irradiated with 25 J/m2 and
followed for the indicated times. (D) Densitometric analysis of pol and P-S687 after UV irradiation. The signal of P-S687 was corrected for the levels of
total pol. The plots represent the mean of three experiment ±S.E.M.
that the two phosphorylated regions are independently reg-
ulated as S687 is still phosphorylated in the SSSAAA mu-
tant, indicating that the putative phosphorylation of S510,
S512, S514 is not a prerequisite for the modification of S687
(Figure 5A, compare lane 2 with lane 4).
The phosphorylation of pol analyzed by 2D PAGE ap-
peared to follow the progression of the cell cycle. To assess
if S687 followed the same pattern and accounted for a part
of the global cell cycle phosphorylation of pol we used
the phospho-specific antibody to analyze pol in a single
cell cycle after double thymidine synchronization. As can
be seen in Figure 5B, phosphorylation of S687 peaks at the
G2/M transition, with an 8-fold increase compared to the
log phase sample, in a manner compatible with our previ-
ous observation (Figure 2A). Interestingly, we also detected
a change in pol protein levels, with the polymerase being
more abundant in S phase andG2/M than in the cells in log
phase, where the G1 phase is more prominent.
As previously stated, pol is phosphorylated on S601
mainly after DNA damage. This holds true for both UV
irradiation but also other DNA damaging treatments (5).
In contrast, phosphorylation of S687 is detectable even in
the absence of DNA damage and for this reason we specu-
lated that it might be controlled in a different manner. To
test the kinetics of phosphorylation of S687 after genotoxic
insult we treated the cells with UV-C light and monitored
the presence of P-S687 over time. In contrast to what was
recently reported (11) while this paper was in preparation,
P-S687 levels did not increase after damage but slowly di-
minished, being halved 24 h after irradiation (Figure 5C and
D). This suggested a marked difference from P-S601. Inter-
estingly the level of pol itself also changed slightly (Figure
5C and D) after UV damage in accordance with what was
previously observed in Caenorhabditis elegans (8,24). It is
important to mention that the signal of P-S687 shown in
Figure 5D was corrected for the levels of total pol, so the
decrease in phosphorylation could not be explained simply
by the reduction in the total amount of the polymerase.
The phosphorylation sites are important for damage bypass
and cell survival
To test the effect of the different newly discovered phospho-
rylated residues on TLS, we used a series of XP30RO cells
stably expressing different alleles of pol. The cell lines ex-
pressed eGFPpolWT, S601A, S687A and SSSAAA. The
cells were then sorted to perform the experiments with cells
expressing polat the same, near physiological, level. To as-
sess for TLS proficiency, we monitored the cells in a clono-
genic survival assay after increasing doses of UV. XP30RO
cells are extremely sensitive to UV irradiation followed by
incubation in the presence of caffeine and this has been
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used as a diagnostic assay for a number of years. As can be
seen in Figure 6A, expression ofWT eGFPpol rescued the
UV sensitivity. Consistent with our previous report (5) the
S601A mutant shows a lower survival than WT pol. Mu-
tating S687 to alanine resulted in similar sensitivity and the
survival rates of S601A and S687A are nearly identical. The
triple S510512514A mutant appears to show a milder phe-
notype, although rescue of the sensitivity to the WT level
was not complete. It is important to note that neither the
S601A nor the SSSmutant affected the levels of phosphory-
lation at S687, as can be seen in Supplementary Figure S2C,
and the signal disappeared only when serine 687 was mu-
tated to alanine. Conversely, the phosphorylation of S601
was not affected in the S687A and SSS mutants suggesting
that phosphorylation of S687 and P-S601 are indeed inde-
pendent events.
To complement this analysis we examined also the post-
replicative repair activity of the different mutants by fol-
lowing the size of nascent DNA in the presence of DNA
damage. UV irradiated cells were pulsed with 3H-thymidine
to label newly replicated DNA, before being chased further
without the radioactive nucleoside. The size of newly syn-
thesized DNA was then determined by running the DNA
on an alkaline sucrose gradient. XP30RO cells cannot by-
pass the damage hence the DNA is replicated in shorter
fragments (right side of the plot in Figure 6B). Complemen-
tation of XP30ROwithWT pol rescues this deficiency and
the cells are able to bypass the damage, resulting in DNA
of larger size (left side of the plot in Figure 6B). All the
mutants analyzed showed an intermediate phenotype, in-
dicating that the damage bypass was impaired, ultimately
resulting in UV sensitivity as shown by the clonogenic sur-
vival. Note that the catalytic activity of pol is unaffected
in these mutants. It remained comparable between all our
pol constructs, as monitored by in vitro primer extension
assays (Supplementary Figure S3A).
Pol phosphorylation controls protein stability
While performing 2D-PAGE experiments we noticed that
the treatment with roscovitine made the visualization of
pol difficult. This required longer exposures for detection
of the polymerase by western blot. Initially we linked this
phenomenon to a decrease in protein expression after treat-
ment with the CDK inhibitor. Roscovitine, by inhibiting the
phosphorylation of RNApolII, is known to affect the rate
of transcription of a number of genes (25). In agreement
with this, we observed a drop in the levels of polmRNA
to around 30–50% of the original levels within 6 h of in-
cubation with roscovitine, as monitored by qPCR (Figure
7A). The protein levels of polappeared to be affected even
more, as the roscovitine treatment resulted in a 70% reduc-
tion after 3 h and more than a 90% decrease after 6 h (lane
2 and 5 respectively of Figure 7B). The substantial decrease
of pol at 6 h indicated that the reduction in protein lev-
els could not be explained only by a block of transcription.
To test if protein degradation was involved in this process
we combined the treatment with roscovitine with the pro-
teasome inhibitor MG132. The concurrent incubation of
MG132 and roscovitine led to a rescue of this phenomenon
(compare lanes 4 and 7 with lane 1 Figure 7B) and we could
observe a stabilization of pol, resulting in a 7-fold increase
at 6 h, evenwhen its phosphorylationwas blocked (compare
lanes 5 with lane 7 Figure 7B). During these experiments we
did not observe a significant difference in the cell cycle dis-
tribution, so we could exclude the possibility that the effects
we detected resulted from the cells accumulating in different
phases of the cell cycle upon drug treatments (Supplemen-
tary Figure S4A).
During our studies we also found that the stable cell line
carrying the S687A allele of pol expressed the transgene
reproducibly at a lower level (approximately at 30% of WT)
than the matching control (Figure 7C, lane 1 and 5). This
was a feature that we observed in multiple independent
clones (data not shown) even after cell sorting, suggesting
that it was not due to the chromosomal locus where the
transgene was integrated. This observation was again con-
sistent with a possible role of the phosphorylation of S687
in controlling the polymerase stability. We reasoned that if
that were the case, blocking the proteasome with MG132
should restore the protein levels of the S687Amutant to the
levels of theWT, possibly with a faster accumulation kinetic
after addition of the drug. As can be seen in Figure 7C, ex-
posure toMG132 for just 1 h resulted in doubling the levels
of the S687Amutant (compare lane 5 and 6) while very little
effect was detected for the WT control (lane 1 and 2). After
6 h of proteasome inhibition, the mutant protein reached
the same protein level as its matched control (compare lane
4 and 8).
These two pieces of experimental evidence point to an im-
portant role for the phosphorylation in controlling polsta-
bility. We also showed that the pol protein fluctuates dur-
ing a cell cycle (Figure 5B), increasing toward late S and
G2/M phases, matching the pattern of appearance of S687
phosphorylation. If the increase in pol stability was due
to the establishment of phosphorylation, we predicted that
the S687A protein level would not change during a cell cy-
cle. To test this hypothesis we synchronized the cells in early
S phase by double thymidine block before releasing them.
Again, the WT showed an increase of pol in S and G2/M
before dropping in the G1 of the next cell cycle. Consis-
tent with our hypothesis the S687Amutant showed (i) lower
overall protein levels; (ii) hardly any fluctuation in poldur-
ing the cell cycle (Figure 7D and E).We conclude that phos-
phorylation of S687 is important for the regulation of pol
protein stability throughout the cell cycle.
DISCUSSION
DNA polymerase  protects the genome by allowing the
completion of replication during stress conditions and can
bypass CPDs in an error-free manner. Regardless of this
characteristic, pol is potentially an error prone polymerase
and, along with the other TLS polymerases, it has to be
correctly regulated. In yeast, part of the control of TLS is
achieved by transcriptional regulation and protein stability
(26,27). In human cells, the current working model is that
TLS polymerases are controlled by modulating their access
to the replication fork by protein–protein interactions and
by PTMs. In the case of pol, the protein levels have been
reported to be constant throughout the cell cycle (28).
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Figure 6. S687 is important for damage bypass and cell survival after UV. (A) Clonogenic survival of XP30RO cells expressing various mutant alleles of
pol (n> 3± S.E.M). Statistical significance was assessed by t-test: **P= 0.0031, ***P< 0.0001. The inset shows the survival of the cell lines at 6 J/m2 on
a linear scale. (B) Damage bypass assay using alkaline sucrose gradient fractionation of newly-synthesized DNA. The inset shows the normalized average
molecular weight of DNA from the distributions (n = 3 ± S.E.M).
Here we show that pol is phosphorylated by CDK2 dur-
ing an unperturbed cell cycle, with a peak in G2/Mand this
phosphorylation is important for regulating its stability and
activity.We further identify the sites where thismodification
occurs and demonstrate that missense mutations at these
sites affect TLS.
The identification of phosphorylation during an unper-
turbed cell cycle complements our previous observation
that pol was phosphorylated on serine 601 after DNA
damage (5). These lines of evidence suggests that phospho-
rylation plays an even more important role in the frame-
work of TLS regulation. It is interesting to note that Pol
is phosphorylated in a similar manner and its phosphory-
lation on multiple sites by CDK2 protects it from ubiquitin
mediated protein degradation in late S and G2 (29).
Increasing the levels of pol during S phase, with a peak
after the bulk of DNA replication is completed provides an
appealing form of control to avoid excessive recruitment of
a potentially inaccurate polymerase during replication (Fig-
ure 8). On the other hand, once the bulk of DNA replica-
tion finishes and any remaining gaps in the DNA become a
threat to cell survival, increasing the amount of polwould
improve the cell’s ability to bypass the damaged bases and
complete DNA replication. In this situation the presence of
pol provides a crucial viability advantage even if the poly-
merase is inaccurate and could generate mutations in the
genome. This model of action is in agreement with observa-
tions in yeast andmammalian cells, which showed that TLS
was able to function also in late G2 and was not limited to
the replicating phase (28,30).
The demonstration that cell-cycle phosphorylation of
pol peaks in G2/M suggests a molecular mechanism for
this kind of regulation. Interestingly Rev1, another TLS
polymerase, has also been found to accumulate in G2 in S.
cerevisiae (26).
Recently Dai et al. identified the phosphorylation of Ser-
ine 687 of pol by immunoprecipitating Flag-tagged pol
followed by MS (11). They detected a time-dependent in-
Downloaded from https://academic.oup.com/nar/article-abstract/45/16/9441/4002723/Phosphorylation-regulates-human-pol-stability-and
by Sussex University user
on 11 October 2017
9452 Nucleic Acids Research, 2017, Vol. 45, No. 16
Figure 7. Phosphorylation of pol is important for its stability. (A) Transcript levels of pol after CDK inhibition. (B) Polprotein levels after roscovitine
treatment, in the presence ofMG132. Relative protein levels normalized to the untreated sample are displayed in red under the eGFPpolblot. (C) XP30RO
cells expressing eGFPpolWT or S687A were incubated with MG132. Relative protein levels normalized to the 0 h sample of each allele are displayed in
bold italic under the eGFPpol blot. (D) XP30RO cells expressing eGFPpolWT or S687A were synchronized by double thymidine block and followed
in the cell cycle after release in nocodazole for 16 h, before final removal of the drug for 3 h. (E) Densitometric analysis of pol levels, either WT or S687A,
during the cell cycle (mean of three experiments ± S.E.M).
crease in P-S687 after UV irradiation and they speculated
that P-S687 mediated the release of the polymerase from
PCNA after damage bypass was completed. This model
originated from the observation that a C-terminal fragment
of pol carrying a S687D mutation had lower affinity for
PCNA in vitro. By using a phospho-specific antibody we
have shown instead that P-S687 decreases over time after
UV (Figure 5). One possible explanation for this discrep-
ancy lies in the fact that Dai et al. used nocodazole in some
of their experiments after UV irradiation, thus increasing
the percentage of cells in G2/M. As we have shown, in
G2/M the phosphorylation of S687 increases substantially
in an unperturbed cell cycle so the compounded effect of
UV and nocodazole treatments may have masked the de-
crease we have observed and resulted in a net apparent in-
crease of P-S687. Furthermore, we failed to observe any dif-
ference in binding to PCNA in vitro between full length pol
and pol phosphorylated on S687 (Supplementary Figure
S3B). Both studies suggest that CDK2 is involved in pol
phosphorylation and that S687 could be important for end-
ing TLS activity after damage is bypassed.
The C-terminus of pol contains a number of important
regulatory domains such as theNLS (aa 682–694), theUBZ
(aa 633–654) and the PIP (aa 701–708). Furthermore, fol-
lowing DNA damage pol is phosphorylated on S601 by
ATR. Serine 687 is located in the region that is also referred
to as PIR that spans from the canonical PIP to the NLS
and contains four lysines that can be ubiquitylated in the
absence of DNA damage (4). We confirmed that the S687A
mutation did not impair the correct localization of the poly-
merase (data not shown) and pol appears to be ubiquity-
lated normally (see Supplementary Figure S2C). Our anal-
ysis of P-S687 enables us also to propose that S687 is likely
phosphorylated on the diffusing fraction of the polymerase,
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Figure 8. Proposed model of phosphorylation-controlled TLS. During an unperturbed cell cycle pol becomes phosphorylated by CDK2 on Serine 687
from late S to G2/M. This results in the accumulation of the polymerase, which is available for bypass activity (left panel). After damage, phosphorylated
pol is recruited to the chromatin via its UBZ (1) and it is further phosphorylated on S601 by ATR. Once S601 has been phosphorylated, pol can interact
with Ubiquitylated PCNA and perform TLS (2). Once the damage has been bypassed P-S687 is removed (3) leading to pol degradation (4).
for two reasons: (i) phosphorylation occurs in the absence
of DNA damage when the majority of pol is not associ-
ated with DNA. (ii) The phosphorylation is not altered in
the UBZmutant (not shown) where pol recruitment to the
chromatin is severely hindered. Both inC. elegans andmam-
malian cells, pol appears to be degraded after UV (8) in
order to keep the TLS polymerase engaged at a minimum.
In C. elegans, SUMOylation of polprotects it from degra-
dation by CUL4/Cdt2 and it is removed after damage by-
pass, leading to removal of the polymerase. In human cells,
SUMOylation of pol has been recently identified but with
a completely different function (9). Our data suggest that
phosphorylation could play a role similar to SUMOylation
inC. elegans, as S687 defective alleles show enhanced degra-
dation. Furthermore after UV, P-S687 is removed with ki-
netics similar to that of pol degradation. Serine 687 thus
provides an appealing candidate to play the role of regu-
lator of pol, making the polymerase available during the
cell cycle and protecting it in the first few hours after DNA
damage. In these first crucial moments, pol, stabilized by
the phosphorylation of S687, is recruited to DNA via its
UBZ.Once on the chromatin,ATRcan phosphorylate S601
on pol and the polymerase can interact with ubiquitylated
PCNA becoming proficient for damage bypass. Once TLS
has been completed P-S687 is removed and this in turn leads
to a decrease in pol that could favor resumption of normal
replication (Figure 8). How the phosphorylation regulates
degradation is an open question.
In recent years, several lines of evidence suggest that pol
is important for the bypass of difficult to replicate templates,
such as common fragile sites (CFS), even in the absence of
damage (31,32). CFS are replicated in late S phase and a
large percentage are still unreplicated as the cell enters G2
(33,34). The replication timing of CFS strikingly matches
the accumulation of poland it is tempting to speculate that
the accumulation we observe of the polymerase in G2/M
could be linked with its CFS bypass role.
It is also interesting to note that damage bypass is im-
paired in vivo in the phosphorylation mutants, although
their catalytic activity is unaffected in vitro. As all the func-
tional assays were performed after cell sorting, we can ex-
clude the possibility that the phenotype is merely dependent
on reduced protein levels, as the cells expressed the different
alleles at similar levels right after sorting, comparable to en-
dogenous pol inMRC5 cells (Supplementary Figure S4B).
Our results complement a recent finding that unveiled
how the C-terminus of polwas important for protein sta-
bility, by analyzing a mutant allele derived from an XPV
patient (10,35). One of the mutations present in XP872VI
was a T692A transversion in addition to a STOP codon loss
that resulted in a protein with eight extra aminoacids (35).
Threonine 692 is located just outside the CDK2 consensus
and still in the polNLS. It is plausible that part of the en-
hanced degradation of the allele resulted from its defective
phosphorylation, further supporting the physiological im-
portance of serine 687 and phosphorylation in general in
controlling TLS.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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